(Total Views: 630)
Posted On: 01/29/2019 1:06:33 PM
Post# of 32974
Another successful OTC graduate: Avalon Globocare Corp
Mkt cap $477.82M
3rd Quarter Revenues: $413K
Market Cap is 1055 x quarterly revenues or about 300 x yearly
Let's say nFusz/SC only have revenues of $14M. That would make it a $4B stock using that same math. Why is Avalon so high. Potential and they had a few good announcements. What is nFusz potential valued out. That's up to each investor to determine.
They did a RS two years ago. Uplisted to the NASDAQ a few months ago and are now doing upto a $50M offering.
"Avalon Globocare provides another example of an OTC company that was able to uplist to a higher exchange."
https://pubcoceo.com/2019/01/17/uplisting-com...obal-corp/
Avalon GloboCare's stock rockets to pace premarket gainers after positive study results
https://www.marketwatch.com/story/avalon-glob...2019-01-28
Mkt cap $477.82M
3rd Quarter Revenues: $413K
Market Cap is 1055 x quarterly revenues or about 300 x yearly
Let's say nFusz/SC only have revenues of $14M. That would make it a $4B stock using that same math. Why is Avalon so high. Potential and they had a few good announcements. What is nFusz potential valued out. That's up to each investor to determine.
They did a RS two years ago. Uplisted to the NASDAQ a few months ago and are now doing upto a $50M offering.
"Avalon Globocare provides another example of an OTC company that was able to uplist to a higher exchange."
https://pubcoceo.com/2019/01/17/uplisting-com...obal-corp/
Avalon GloboCare's stock rockets to pace premarket gainers after positive study results
https://www.marketwatch.com/story/avalon-glob...2019-01-28
(14)
(0)
